Nothing Special   »   [go: up one dir, main page]

AU3863997A - Treatment of the acute infant's diarrhoea and prevention of allergic reactions to foods swallowed in the following phase by administering lactobacillus gg in the oral rehydrating solution - Google Patents

Treatment of the acute infant's diarrhoea and prevention of allergic reactions to foods swallowed in the following phase by administering lactobacillus gg in the oral rehydrating solution

Info

Publication number
AU3863997A
AU3863997A AU38639/97A AU3863997A AU3863997A AU 3863997 A AU3863997 A AU 3863997A AU 38639/97 A AU38639/97 A AU 38639/97A AU 3863997 A AU3863997 A AU 3863997A AU 3863997 A AU3863997 A AU 3863997A
Authority
AU
Australia
Prior art keywords
diarrhoea
swallowed
foods
prevention
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU38639/97A
Inventor
Stefano Guandalini
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
DICOFARM SpA
Original Assignee
DICOFARM SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by DICOFARM SpA filed Critical DICOFARM SpA
Publication of AU3863997A publication Critical patent/AU3863997A/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • A61K35/741Probiotics
    • A61K35/744Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747Lactobacilli, e.g. L. acidophilus or L. brevis

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU38639/97A 1996-08-09 1997-08-04 Treatment of the acute infant's diarrhoea and prevention of allergic reactions to foods swallowed in the following phase by administering lactobacillus gg in the oral rehydrating solution Abandoned AU3863997A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ITRM96A0571 1996-08-09
IT96RM000571A IT1284877B1 (en) 1996-08-09 1996-08-09 TREATMENT OF ACUTE DIARRHEA IN CHILDREN AND PREVENTION OF ALLERGIC SENSITIZATION TO FOODS INTRODUCED DURING THE PHASE
PCT/IT1997/000201 WO1998006411A2 (en) 1996-08-09 1997-08-04 Use of lactobacillus gg in the rehydrating solution

Publications (1)

Publication Number Publication Date
AU3863997A true AU3863997A (en) 1998-03-06

Family

ID=11404390

Family Applications (1)

Application Number Title Priority Date Filing Date
AU38639/97A Abandoned AU3863997A (en) 1996-08-09 1997-08-04 Treatment of the acute infant's diarrhoea and prevention of allergic reactions to foods swallowed in the following phase by administering lactobacillus gg in the oral rehydrating solution

Country Status (4)

Country Link
EP (1) EP0918531A2 (en)
AU (1) AU3863997A (en)
IT (1) IT1284877B1 (en)
WO (1) WO1998006411A2 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2785809B1 (en) 1998-11-18 2001-01-12 Gervais Danone Sa SELECTION AND USES OF STRAINS OF LACTIC BACTERIA MODULATING NON-SPECIFIC IMMUNITY
EP1034787A1 (en) 1999-03-11 2000-09-13 Société des Produits Nestlé S.A. Lactobacillus strains preventing diarrhea caused by pathogenic bacteria
US6887465B1 (en) * 1999-03-11 2005-05-03 Nestec S.A. Lactobacillus strains capable of preventing diarrhoea caused by pathogenic bacteria and rotaviruses
EP1034788A1 (en) * 1999-03-11 2000-09-13 Société des Produits Nestlé S.A. Lactic acid bacteria strains capable of preventing diarrhea
BR0111584A (en) * 2000-06-13 2003-05-06 Unilever Nv Method for the production of a food product comprising non-viable lactobacillus bacteria, and, food product
ES2277550B1 (en) * 2005-12-21 2008-06-16 Laboratorios Casen-Fleet, S.L. PHARMACEUTICAL KIT FOR THE PREPARATION OF A HYDRATION SALT WITH A BABY PROBIOTIC.
EP2455094A1 (en) 2010-11-11 2012-05-23 Nestec S.A. Non-replicating probiotic micro-organisms protect children against gastrointestinal infections

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4839281A (en) * 1985-04-17 1989-06-13 New England Medical Center Hospitals, Inc. Lactobacillus strains and methods of selection
AU624067B2 (en) * 1986-12-12 1992-06-04 Biorem C.C. Preparation suitable for use in the treatment of enteric disorders
CA2081388A1 (en) * 1990-04-09 1991-10-10 Jonah Shacknai Antidiarrheal composition and method
US5413785A (en) * 1993-01-27 1995-05-09 New England Deaconess Hospital Corp. Methodology employing lactobacillus GG for reduction of plasma endotoxin levels circulating in-vivo
CA2156859A1 (en) * 1993-02-24 1994-09-01 Sherwood L. Gorbach Method of enhancing immune response to oral vaccines

Also Published As

Publication number Publication date
EP0918531A2 (en) 1999-06-02
ITRM960571A1 (en) 1998-02-09
WO1998006411A3 (en) 1998-05-07
WO1998006411A2 (en) 1998-02-19
ITRM960571A0 (en) 1996-08-09
IT1284877B1 (en) 1998-05-22

Similar Documents

Publication Publication Date Title
AU5844598A (en) Improvements relating to hygiene and medical products
CA2229624A1 (en) Method of reducing bodyweight and treating obesity
IL107518A0 (en) Therapeutic and diagnostic compositions comprising purified surface modifiers to prevent particle aggregation during sterilization
CA2294099A1 (en) Absorption of minerals
AU2249892A (en) Diagnosis and treatment of arterial chlamydial granuloma
ZA899176B (en) Use of acetyl d-carnitine in the therapeutic treatment of glaucoma and pharmaceutical compositions useful in such treatment
AU1937395A (en) Pharmaceutical compositions containing alkylthioalkanoic acids or derivatives thereof and their use in the treatment of mycobacterial infections and as antiseptic
GR3019625T3 (en) Topically administered compositions based on high molecular weight hyaluronic acid for treating inflammations of the oral cavity, and for oral cavity hygiene and cosmetic treatment
IL130784A0 (en) Use of an anti-cd40l compound in the manufacture of a medicament for treating a patient with immune complex disease and pharmaceutical compositions containing the same
AU2300001A (en) Pharmaceutical compositions useful in the prevention and treatment of beta-amyloid protein-induced disease
AU2466695A (en) The use of famotidine and related compounds in the treatment of movement disorders
AU1492401A (en) Cleanser that is gentle to human skin
AU2463099A (en) Gabapentin and its derivatives for the treatment of muscular and skeletal pain
AU5911994A (en) Oral formulations of ubidecarenone in the form of capsules
WO2000074712A3 (en) Composition comprising alkaline sphingomyelinase for use as a dietetic preparation, food supplement or pharmaceutical product
AU3863997A (en) Treatment of the acute infant's diarrhoea and prevention of allergic reactions to foods swallowed in the following phase by administering lactobacillus gg in the oral rehydrating solution
HK1026637A1 (en) Compositions for administering taxanes orally to human patients and their use
AU4210696A (en) Use of AICA riboside compounds for the treatment and prevention of tissue damage due to decreased blood flow
HUP9904294A3 (en) Topiramate derivatives and their use for producing medicament useful in the treatment of neuropathic pain
AU2001282730A1 (en) Seal-oil-based pharmaceutical, cosmetic, dermo-cosmetic, hygiene, alimentary andpara-alimentary (food-supplements) products; their methods of preparation; thei r uses as preventive and/or as therapeutic agents
GB9316615D0 (en) Improvements in or relating to the ultrasonic detection of dental caries
ZA967319B (en) Preparation of pharmaceutical grade hemoglobins by heat treatment in partially oxygenated form
FR2685867B1 (en) COMPOSITIONS AGAINST DEQUAMATION OF THE SKIN AND SCALP.
AU2742395A (en) Therapeutic or dietetic composition in the form of medicinal gel for the administration to pets
ZA944281B (en) Use of efaroxan and its derivatives for the preparation of a medicinal product intented for the treatment of parkinson's disease